🚨 The wait is over — registration and abstract submissions are officially open for #PVRI2026. With the theme of Celebrating 20 Years of Progress & Innovation, join us in Dublin from 28 January – 1 February for world-class science, dynamic discussions, and impactful networking

Great news! Key findings just published in the ERJ Open Research from our Pulmonary Hypertension Global Patient Survey #PHGPS adult cohort of 3,329 patients highlight the achievements, shortcomings & regional disparities of #PH clinical care & research globally. Findings in the

How to use imaging endpoints reflecting the pulmonary circulation & RV - catch up on David Kiely's insightful talk from #DDDS2025 as he explores:. 🔹 Why do we need to consider using an imaging end-point in PH trials?.🔹 What imaging can we use to assess the cardiopulmonary

Missed it? Catch up on @DrRahulKumarPhD presentation on the role of inflammatory immune cells in hypoxic pulmonary hypertension. 🎥 Now available to watch on demand — free to access:.#HighAltitude #Hypoxia #PulmonaryHypertension #Webinar.

RT @EuropePHA: PHA Europe was proud to be represented by Hall Skaara at the PVRI Drug Discovery & Development Symposium 2025 in Amsterdam.….

Happening tomorrow! Register & join for free

📝 Hall Skaara shares his reflections on #DDDS2025. We loved reading this brilliant write-up by Hall Skaara from @EuropePHA, capturing key moments and takeaways from our Drug Discovery & Development Symposium 2025 in Amsterdam. From global collaboration to patient access and the.

New publication: Hypopituitarism Induced by Continuous Infusion of PGI2 Analogues: A Case Series and the Role of ACTH Screening and Hydrocortisone Treatment by Taijyu Satoh Et al. Read the full research article

🎥 Missed #DDDS2025 in Amsterdam?.Catch Luke Howard’s talk: How Sotatercept will change the treatment algorithm 💊.▶️ Full recording: @HelpMyBreathing.#PHResearch #DrugDevelopment #Sotatercept #PVRI

Next in our High Altitude webinar series 'Hypoxia in Pulmonary Vascular Research – Altitude and Beyond'🗻. 📅 1 July 2025 | 1PM BST.🎙️ Join @DrRahulKumarPhD as he explores the role of inflammatory immune cells in hypoxic pulmonary hypertension. Moderated by @aastha_mishra06 &

New publication: Melatonin Improves Quality of Life, Oxidative Stress, and Cardiovascular Function in Pulmonary Arterial Hypertension by Alicia de la Fuente Et al. Read the full research article

RT @sbonnet2: Our latest review on Anti-remodeling therapies in pulmonary arterial hypertension: Trends in Pharmacological Sciences https:/….

That’s a wrap! A huge thank you to all our delegates & speakers who joined us in this amazing city. We are so grateful to you all and we hope you have taken away some valuable insights and meaningful connections that will continue to drive our shared vision forward. #DDDS2025

What a lovely evening last night at our drink’s reception. Great conversations, new connections, and a perfect way to unwind after a busy day of scientific presentations. Thank you to everyone who joined us! #DDDS2025

Fantastic panel discussion this afternoon for our 'Global aspects of drug development & availability' session. Thank you to our wonderful moderators & speakers, Anton Vonk Noordegraaf, Deimante Hoppenot, Werner Seeger, Anna Hemnes, Ardeschir Ghofrani #DDDS2025

The debate has begun! 🎤 Friendly sparks are flying as Anna Hemnes and Ardeschir Ghofrani go head-to-head on ‘It is Big Pharma’s responsibility to prioritise drug availability over drug discovery?’ 💥 #DDDS2025

Werner Seeger is kicking off the afternoon presentations with a talk on using the GoDeep registry to prioritise & facilitate global drug trials. PVRI GoDeep is a global meta-registry of #pulmonaryhypertension patients, including currently nearly 40,000 patients from 47 PH

What a morning at #DDDS2025! Great to hear so many insightful presentations already on new standards of care and disease modification. Here’s some highlights: .🔬 After Anna Hemnes’s welcome, Mitchell Psotka (FDA) and Illiana Meurs (CBG-MEB) opened with a presentation on global

Welkom in Amsterdam! We’re now live for #DDDS2025 and we’re so excited to kick off our scientific presentations, with the theme of ‘Inclusive and sustainable drug development for PAH’.